LONG-ACTING FORMULATIONS OF INSULIN GLARGINE
The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Isabell Schoettle Katrin Tertsch Reinhard Becker Petra Loos Annke Frick Ulrich Werner Christiane Fuerst Peter Boderke Werner Mueller |
| description | The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HK1248592A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HK1248592A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HK1248592A13</originalsourceid><addsrcrecordid>eNrjZNDx8fdz13V0DvH0c1dw8w_yDfVxDPH09wtW8HdT8PQLDvXx9FNw93EMcvf0c-VhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEe3oZGJhamlkaOhsZEKAEAXpQk6w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LONG-ACTING FORMULATIONS OF INSULIN GLARGINE</title><source>esp@cenet</source><creator>Isabell Schoettle ; Katrin Tertsch ; Reinhard Becker ; Petra Loos ; Annke Frick ; Ulrich Werner ; Christiane Fuerst ; Peter Boderke ; Werner Mueller</creator><creatorcontrib>Isabell Schoettle ; Katrin Tertsch ; Reinhard Becker ; Petra Loos ; Annke Frick ; Ulrich Werner ; Christiane Fuerst ; Peter Boderke ; Werner Mueller</creatorcontrib><description>The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use.</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181019&DB=EPODOC&CC=HK&NR=1248592A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181019&DB=EPODOC&CC=HK&NR=1248592A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Isabell Schoettle</creatorcontrib><creatorcontrib>Katrin Tertsch</creatorcontrib><creatorcontrib>Reinhard Becker</creatorcontrib><creatorcontrib>Petra Loos</creatorcontrib><creatorcontrib>Annke Frick</creatorcontrib><creatorcontrib>Ulrich Werner</creatorcontrib><creatorcontrib>Christiane Fuerst</creatorcontrib><creatorcontrib>Peter Boderke</creatorcontrib><creatorcontrib>Werner Mueller</creatorcontrib><title>LONG-ACTING FORMULATIONS OF INSULIN GLARGINE</title><description>The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDx8fdz13V0DvH0c1dw8w_yDfVxDPH09wtW8HdT8PQLDvXx9FNw93EMcvf0c-VhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEe3oZGJhamlkaOhsZEKAEAXpQk6w</recordid><startdate>20181019</startdate><enddate>20181019</enddate><creator>Isabell Schoettle</creator><creator>Katrin Tertsch</creator><creator>Reinhard Becker</creator><creator>Petra Loos</creator><creator>Annke Frick</creator><creator>Ulrich Werner</creator><creator>Christiane Fuerst</creator><creator>Peter Boderke</creator><creator>Werner Mueller</creator><scope>EVB</scope></search><sort><creationdate>20181019</creationdate><title>LONG-ACTING FORMULATIONS OF INSULIN GLARGINE</title><author>Isabell Schoettle ; Katrin Tertsch ; Reinhard Becker ; Petra Loos ; Annke Frick ; Ulrich Werner ; Christiane Fuerst ; Peter Boderke ; Werner Mueller</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HK1248592A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2018</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Isabell Schoettle</creatorcontrib><creatorcontrib>Katrin Tertsch</creatorcontrib><creatorcontrib>Reinhard Becker</creatorcontrib><creatorcontrib>Petra Loos</creatorcontrib><creatorcontrib>Annke Frick</creatorcontrib><creatorcontrib>Ulrich Werner</creatorcontrib><creatorcontrib>Christiane Fuerst</creatorcontrib><creatorcontrib>Peter Boderke</creatorcontrib><creatorcontrib>Werner Mueller</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Isabell Schoettle</au><au>Katrin Tertsch</au><au>Reinhard Becker</au><au>Petra Loos</au><au>Annke Frick</au><au>Ulrich Werner</au><au>Christiane Fuerst</au><au>Peter Boderke</au><au>Werner Mueller</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LONG-ACTING FORMULATIONS OF INSULIN GLARGINE</title><date>2018-10-19</date><risdate>2018</risdate><abstract>The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_HK1248592A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | LONG-ACTING FORMULATIONS OF INSULIN GLARGINE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T14%3A12%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Isabell%20Schoettle&rft.date=2018-10-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHK1248592A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |